Posted Mon, Aug, 13,2012
Enhanced visibility is one of the prime advantages to authors of publishing in an open access journal like Clinical Medicine Insights: Women's Health.
One of the ways we measure an article's visibility is the number of views and downloads it receives. The resulting number is available on the journal's webpages for each article, and by adding those numbers together we obtain the journal's visibility figure.
Counting views and downloads is complicated by the possibility of fraud and automated views by search engines. To ensure that readers and authors can have confidence in our visibility analytics we have now formally joined Project Counter. Release 3 of Project Counter's code of practice addresses these and other problems.
Clinical Medicine Insights: Women's Health's membership of Project Counter ensures that readers and authors can trust its visibility analytics.
Visit this page to see the latest visibility information for Clinical Medicine Insights: Women's Health
Fri 24 May, 2013Article Usage Metrics Now Available for all Journals
Fri 24 May, 2013Treatment of Recurrent HNSCC
Fri 24 May, 2013Bilateral Renal Infarction in a Lupus Patient
I have had contact with Drug Target Insights several times, and every time I am impressed by the handling of the manuscript. The website is very, very user-friendly. It is easy to submit a manuscript. The entire process is easy and straightforward. The corresponding author is kept updated on the progress at every point. The editors of Libertas were helpful and prompt in responding to questions and issues related to the submission I am pleased ...
All authors are surveyed after their articles are published. Authors are asked to rate their experience in a variety of areas, and their responses help us to monitor our performance. Presented here are their responses in some key areas. No 'poor' or 'very poor' responses were received; these are represented in the 'other' category.See Our Results
Copyright © 2013 Libertas Academica Ltd (except open access articles and accompanying metadata and supplementary files.)